Differences in glycemic control across world regions: a post-hoc analysis in patients with type 2 diabetes mellitus on dual antidiabetes drug therapy

por Brath, H, Paldánius, P M, Bader, G, Kolaczynski, W M, Nilsson, P M
Publicado 2016

Effectiveness and tolerability of second-line therapy with vildagliptin vs. other oral agents in type 2 diabetes: A real-life worldwide observational study (EDGE)

por Mathieu, C, Barnett, A H, Brath, H, Conget, I, de Castro, J J, Göke, R, Márquez Rodriguez, E, Nilsson, P M, Pagkalos, E, Penfornis, A, Schaper, NC, Wangnoo, S K, Kothny, W, Bader, G
Publicado 2013